Defiance Daily Target 2X Long XOVR ETF
XOVL · ETF
About XOVL
- Issuer
- Defiance
- Expense ratio
- 1.31%
- Assets under management
- $4.63M
- Inception
- May 4, 2026
- Asset class
- Equity
- Website
- defianceetfs.com
XOVL key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 3.64K
- Volume
- 1.18K
- Open price
- $19.51
- High today
- $19.57
- Low today
- $19.31
- 52 Week high
- $25.17
- 52 Week low
- $16.91
Defiance Daily Target 2X Long XOVR ETF (XOVL) at a glance
Defiance Daily Target 2X Long XOVR ETF (XOVL) last traded at $19.36, with a price-to-earnings ratio of 0.00.
Today the fund has traded between $19.31 and $19.57. The current price is 0.3% above the day's low and 1.1% below its high.
Volume so far is 1.18K shares, below the average of 3.64K shares a day.
Over the past year Defiance Daily Target 2X Long XOVR ETF has ranged from $16.91 to $25.17, and now sits 30% of the way up that range.
XOVL news
- Chandrima Sanyal
- Chandrima Sanyal
Chasing Pre-IPO Alpha: Defiance Unveils 2X Leveraged Private-Public Crossover ETF
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.